Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2022-09-23 00:00:00 ET · period of report 2022-09-22 · accession 0001493152-22-026629 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-23 | 2022-09-22 | ETON | BRYNJELSEN SEAN | CEO, Dir | P - Purchase | $2.10 | +10.0K | 1.04M | +1.0% | +$21.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-22 | P | A | 10,000 | $2.10 | 1,040,000 | D | — | — |